| |
Syntide 2  |
|
|

| Cat. No. |
Size |
Price |
Figures |
RP10322-1 mg
| 1 mg | $ 38.00 | HPLC: 20060721145615 (PDF) MS: 20060721145555 (PDF) MSDS: 20080626234630 (PDF) STRUCTURE:
 Zoom
References:
- Lin X, et al. Salt-inducible kinase is involved in the ACTH/cAMP-dependent protein kinase signaling in Y1 mouse adrenocortical tumor cells. Mol Endocrinol. Aug 2001;15(8):1264-1276.
- Doi J, et al. Salt-inducible kinase represses cAMP-dependent protein kinase-mediated activation of human cholesterol side chain cleavage cytochrome P450 promoter through the CREB basic leucine zipper domain. J Biol Chem. May 3 2002;277(18):15629-15637.
- Horike N, et al. Adipose-specific expression, phosphorylation of Ser794 in insulin receptor substrate-1, and activation in diabetic animals of salt-inducible kinase-2. J Biol Chem. May 16 2003;278(20):18440-18447.
|
|---|
RP10322-5 mg
| 5 mg | $ 152.00 |
|---|
| Full Name | |
Sequence (one-letter code) |
PLARTLSVAGLPGKK | Sequence (three-letter code) | {PRO}{LEU}{ALA}{ARG}{THR}{LEU}{SER}{VAL}{ALA}{GLY} {LEU}{PRO}{GLY}{LYS}{LYS} | | Description | The native peptide PLARTLSVAGLPGKK is a selective substrate for CaM kinase II and PKC. It is also a poor substrate for phosphorylase kinase and is not phosphorylated by myosin light chain kinase. The sequence of PLARTLSVAGLPGKK is homologous to phosphorylation site 2 in glycogen synthase. The relative Vmax/Km ratios of the peptide for different kinases are 100 for CaMK II, 22 for PKC, 2 for phosphorylase kinase, and 0.5 for myosin light chain kinase, respectively. |
|---|
| Solubility | Soluble in water: clear, colorless, 1 mg/ml H2O |
|---|
| Formula | C68H122N20O18 | | M.W. | 1507.82 | | Cas | 108334-68-5 |
|---|
| Purity | > 95% | | Storage | Store at -20°C. Keep tightly closed. |
| * For Non-Clinical Research Use Only *
Our customer service is available 24 hours a day, Monday through Friday. You may contact us any time for assistance.
|
|